首页> 外国专利> FUSED DLK1-Fc PROTEIN AND USING IT FOR METASTASES INHIBITION, POLYNUCLEOTIDE CODING PROTEIN, VECTOR, HOST CELL, METHOD FOR PRODUCING FUSED PROTEIN, COMPOSITION AND METHOD FOR METASTASES INHIBITION

FUSED DLK1-Fc PROTEIN AND USING IT FOR METASTASES INHIBITION, POLYNUCLEOTIDE CODING PROTEIN, VECTOR, HOST CELL, METHOD FOR PRODUCING FUSED PROTEIN, COMPOSITION AND METHOD FOR METASTASES INHIBITION

机译:融合的DLK1-Fc蛋白及其用于转移酶的抑制,多核苷酸编码蛋白,载体,宿主细胞,融合蛋白的制备方法,组成和转移酶的抑制方法

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: presented group of inventions refers to biotechnology, and concerns a DLK1-Fc fused protein and using it for the metastases inhibition, a polynucleotide coding such a protein, an expression vector containing the polynucleotide, a host cell producing the above fused protein, a method for producing the fused protein by culturing the above host cell, a composition containing the above fused protein, and a method for the metastases inhibition. The characterised fused protein contains a DLK1 extracellular soluble domain consisting of the amino acid sequence SEQ ID NO:4 and Fc domain of a human antibody.;EFFECT: group of inventions can be used for preparing a therapeutic agent for reduction of cancer cell migration and the metastases inhibition.;11 cl, 36 dwg, 3 ex
机译:领域:提出的一组发明涉及生物技术,并且涉及一种DLK1-Fc融合蛋白并将其用于转移抑制,编码该蛋白的多核苷酸,包含该多核苷酸的表达载体,宿主细胞制备上述融合蛋白的方法,通过培养上述宿主细胞制备融合蛋白的方法,包含上述融合蛋白的组合物和转移抑制方法。表征的融合蛋白含有由氨基酸序列SEQ ID NO:4和人抗体的Fc结构域组成的DLK1细胞外可溶性结构域。效果:一组发明可用于制备用于减少癌细胞迁移的治疗剂和转移抑制; 11 cl,36 dwg,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号